Jeff Keelan gained his PhD from the University of Auckland in 1994, moving from Auckland to Perth WA in 2007. Although his research was initially in the field of steroid biochemistry, where he specialised in assay development, his postdoctoral research has primarily focused on the study of the immunology, endocrinology and pharmacology of pregnancy.
He is Professor of Obstetrics and Head of School of Biomedical Sciences at QEII Medical Centre, Perth. He is also Director of the Women and Newborn Health Research Network at King Edward Memorial Hospital. He has supervised more than 50 postgraduate students and published more than 220 articles in the fields of immunology, pharmacology, obstetrics and endocrinology (Google Scholar: >11,000 citations; h-index 61); he has received more than $18 M in competitive grant funding.

His current research is centred on the pharmacological treatment of intra-amniotic infection/inflammation, nanoparticle-based drug delivery in pregnancy, the intrauterine microbial and endocrine environment, amniotic fluid metagenomics, lipidomics and toxicology.

• Head of School of Biomedical Sciences, QEII Medical Centre, Nedlands, Perth
• Research Professor, Division of Obstetrics & Gynaecology
• Director, Women and Newborn Health Research Network (WNHRN), King Edward Memorial Hospital
• Adjunct Professor, Curtin University
• Board Member, Marshall Centre Advisory Board
• Board Member, QEII Trust

I am interested in exploring the prognostic value of assessing maternal inflammation in pregnancy, and the use of drugs, probiotics and dietary supplements to mitigate the effects of inflammation in pregnancy.

Since 2017:

2017:  Chief applicant (CIB) with John Newnham, Dorota Doherty, Matthew Payne. NHMRC project grant APP1111111: “A prospective, open-label, single-centre/multi-site, randomized clinical trial of a novel maternal microbiological “screen & treat” program compared with normal care for the prevention of preterm birth”

2017   Chief applicant (CIA) with David Olson, Sarah Robertson, Matthew Kemp and Hayley Dickinson. NHMRC project grant AP1145295: “Preclinical evaluation of a novel allosteric IL-1R inhibitor (rytvela) for the prevention of perinatal inflammation-induced fetal injury”

2017   Chief applicant (CIB) with Sarah Robertson and Mark Hutchins. NHMRC project grant APP1140916: “Preclinical development of TLR signalling inhibitors for prevention of preterm labour and fetal inflammatory injury”

2017   Co-applicant with Jiake Xu and others, NHMRC Equipment Grant: “iCelligence System”

2017   Co-applicant with J Newnham and others, NHMRC Equipment Grant: “Kingfisher 96-Plex Purification System”

2018   Chief applicant, Channel 7 Telethon Trust Grant: “Multi-omic analysis of cervicovaginal fluids for predicting preterm birth”

2019   Co-applicant, NHMRC Equipment Grant

2020   Co-applicant, NHMRC Equipment Grant

1985 – 94: Hospital Scientific Officer, Dept. Clinical Biochemistry, National Women’s Hospital, Auckland, NZ
1994 – 2001: Postdoctoral Research Fellow and Lecturer, University of Auckland, Dept Pharmacology and Clinical Pharmacology, Auckland, NZ
2001 – 2007: Senior Lecturer, University of Auckland, Auckland, NZ
2006 – 2007: Head, Pregnancy Research Group, Liggins Institute, University of Auckland

2007 - 2020: Head, Women and Infants Health Research Laboratories, KEMH, Perth WA.

Contact Jeff Keelan for details

Lecturing: Molecular Pharmacology; Reproductive biology; Placental pharmacology; Pharmacology in pregnancy.

Uni Western Australia: Lecturer for PHAR2220; ANHB2216; APHB5501; ANHB3316; IMED1108, IMED2208; IMED3308

Uni Auckland: MEDSCI201 (Introduction to Pharmacology and Toxicology): Lecturer and course coordinator.
Uni Auckland: MEDSCI720 (Biomedical research techniques) lecturer and course coordinator.